1 / 22

Practice Guidelines & clinical pathway on management of Dyspepsia

Practice Guidelines & clinical pathway on management of Dyspepsia. Clinical Scenario. 30 year old, male Call center representative Epigastric pain Denies any alarm features Smoker; alcohol and coffee drinker Unremarkable past medical & family history Direct epigastric tenderness.

grahams
Download Presentation

Practice Guidelines & clinical pathway on management of Dyspepsia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Practice Guidelines & clinical pathway on management of Dyspepsia

  2. Clinical Scenario • 30 year old, male • Call center representative • Epigastric pain • Denies any alarm features • Smoker; alcohol and coffee drinker • Unremarkable past medical & family history • Direct epigastric tenderness

  3. Dyspepsia Presence of 1 or more of the following symptoms (Rome III Committee): • Postprandial fullness • Early satiety • Epigastric pain or burning

  4. Assessment & Diagnosis • Based on history and physical and exam • Consider or rule out: • Dietary indiscretion • Medication induced • Cardiac disease • Gastroparesis • Hepatobiliary disorders • Other systemic disease

  5. 4 Major Causes: • Chronic peptic ulcer disease • Gastroesophageal reflux (+/- esophagitis) • Functional dyspepsia (NUD) • Malignancy

  6. Stratify Patients • Age (55 or less/ above 55) • Presence of alarm features • Family history of upper GI cancer • Unintended weight loss • GI bleeding, unexplained anemia • Progressive dyspepsia, odynophagia • Persistent vomiting • Palpable mass or lymphadenopathy • Jaundice

  7. Review of Current Literatures • Peptic ulcer is found in ~5-15% of patients • Gastric or esophageal Adenocarcinoma is identified in <2% of all patients who undergo endoscopy for dyspepsia • Upper gastrointestinal malignancy becomes more common after age 55 years

  8. Review of Current Literatures • Absence of alarm features has a negative predictive value of >97% • Chronic infection with H. pylori is associated with >80% of peptic ulcers and >1/2 of gastric cancers

  9. Patient Profile • 30 year old, male • Burning epigastric pain • No alarm symptoms

  10. Empiric PPI Therapy • Empiric therapy with proton pump inhibitors for 4- 6weeks • Reassurance • No further investigations if symptoms improve • Out patient clinic follow-up

  11. Failed Empirical Therapy • No response to therapy after 7-10 days • Symptoms has not resolved after 6-8 weeks • EGD with biopsy for H. pylori • Organic disease (PUD, GERD, CA) • Treat accordingly

  12. Normal EGD (Functional Dyspepsia) • Reassurance • Lifestyle changes • Treat H. pylori if present • H. pylori regimen: PPI 40 mg 2x a day Amoxicillin 1G 2x a day Clarithromycin 500mg 2x a day (10-14 days)

  13. <55 y/o and below, no alarm features >55 y/o or w/ alarm features Empiric PPI therapy Response Failed empirical therapy EGD with biopsy for H. pylori Functional dyspepsia Organic disease (PUD, GERD, CA) Reassurance Lifestyle modifications Treat H. pylori if (+) Treat accordingly

  14. H. Pylori Follow -up • Patients who remain symptomatic after initial course of treatment should be retested 4 weeks after completion of the course • Urea breath test or stool antigen test • Some success in using previous triple therapy • Switch to another regimen: PPI+metronidazole+bismuth+tetracycline

  15. Unresponsive Functional Dyspepsia • Persistent dyspeptic symptoms • Not infected with H. pylori or have been rendered free of H. pylori • Do not respond to short course of PPI therapy • (-) negative findings on endoscopy

  16. Unresponsive Functional Dyspepsia • Reevaluate diagnosis • Consider: gastroparesis, biliary or pancreatic diseases, IBS, anxiety disorder • Limited data on use of antidepressants, prokinetic agents

  17. References • Talley NJ, Vakil NB, Moayyedi P: American Gastroenterological Association Technical Review: Evaluation of Dyspepsia. Gasteroenterology 2005, 129:1756-1780.   • American Gastroenterological Association Medical Position Statement: Evaluation of Dyspepsia Gastroenterology 2005, 129:1753-1755.  • Lam SK, Talley NJ: Report for the 1997 Asia Pacific. Consensus Guidelines on the management of H. pylori. Journal Gasteroenterology & Hepatology 1998, 13:1-2.   • American Society for Gastrointestinal Endoscopy’s The role of endoscopy in dyspepsia. Gastrointestinal Endoscopy 2007, 6:1071-1075 • Sleisenger and Fordtran’s Gastrointestinal and Liver Disease 8th Edition

  18. Prepared by: • Dr. Ernesto Olympia • Dr. Benjamin Benitez • Dr. Patricia Prodigalidad • Dr. William Rodriguez

  19. Thank you and good day.

  20. Test-and-Treat Approach • Test for H. pylori (Urea Breath Test or Stool Antigen Test) • Treat if (+) • Trial of PPI therapy if (-) • Do endoscopy if no symptom improvement

  21. Need for in-patient work-up and care • Severity of dyspepsia • Alarm symptoms present • Need for additional lab tests and imaging studies

  22. Possible Scenario • 50 year old with CAD on ASA • Severe epigastric pain, weakness, melena • Pale Will need: • Hospital admission for medical management • Early endosocopy, CBC • Blood transfusion

More Related